Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: An Italian multicenter study (MOVIE-GOIRC 01–2014)

Vinflunine is the only chemotherapeutic agent shown to improve survival in platinum-refractory patients with metastatic transitional cell carcinoma of the urothelium (TCCU) in a phase III clinical trial, which led to product registration for this indication in Europe. | Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma An Italian multicenter study MOVIE-GOIRC 01 2014

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG